Director Business Develoment and Operations @ (June 2019 - June 2023)
Vice-Chair - Life Sciences @ (May 2019 - August 2024)
Executive Committee Member @ (October 2018 - July 2024)
Member Administrative Board @ (September 2014 - July 2024)
Chief Business Officer @ (July 2023 - June 2024)
Business Development and CBO @ (September 2021 - July 2023)
Business Development @ (September 2018 - May 2022)
Consultant, Business Development @ (August 2018 - July 2020)
Partner @ Procela Partners (July 2017 - August 2019)
Director Partnering and Licensing @ (August 2016 - December 2017)
Senior Director Business Development @ (September 2015 - July 2017)
MVA Ambassador @ (June 2014 - June 2015)
Advisor and EIR @ North Shore InnoVentures (June 2011 - March 2014)
Consultant @ Biota Holdings Limited (Biota Pharmaceuticals, Inc., acquired by Avirogen) (March 2010 - June 2011)
Co-Founder; Head Chemistry and R and D Operations @ (August 2003 - April 2010)
Founder and Principal @ NEPAssociates (February 2003 - April 2009)
Project Director @ (January 2000 - January 2003)
Associate Director of Chemistry @ RiboGene, Inc.
Senior Scientist @ R. W. Johnson Pharmaceutical Reserarch Institute (October 1989 - February 1998)
Roger Frechette Education
Yale University
NIH Postoctoral Fellowship (Organic Chemistry)
Wesleyan University
Ph.D. (Organic Chemistry)
College of the Holy Cross
BA (Chemistry)
Berlin Senior High School
Roger Frechette Skills
Conceptual Modeling
Scientific Background
Admet
Biology
Engagement
Stocks
Innovator
Transitioning
Clinical Research
Validation
Toxicity
Contract Negotiation
Public Speaking
Strategic Alliances
Translation
Entrepreneurship
Pharmaceutical Industry
Drug Development
Residence
R
R&d
Marketing
Cross Functional Team Leadership
Chemistry
FIX Protocol
High Throughput
Execution
Reproductive Health
Life Sciences
Melbourne
Clinical Development
Market
Multiple Therapeutic Areas
Biopharmaceuticals
Immunology
Mentoring
Science
Strategy
Drug Delivery
Software
Biochemistry
Bioinformatics
Sales
Project Management
Cardiovascular
Payments
Financial Services
Contractual Agreements
Oncology
Product Development
Denmark
Intellectual Property
Stage
Organizer
Cash
Boston
FDA
Operations
GMP
Drug Discovery
GLP
Genomics
Cycles
Networking
Funding
Portugal
Introducing
Biomarker Development
Continuum
Diagnostics
Strategic Partnerships
Equities
Business Development
Bacterial
Lead Generation
Licensing Agreements
Signalling
Business Planning
Assay Development
Scotland
Spain
Medical Devices
Biotechnology
Flat Patterning
Ndas
Good Laboratory Practice Glp
Lifesciences
Technology Transfer
Multi Disciplinary
Project
Mass
Computational Design
Debate
Presentations
Formulation
Connecticut
Inflammation
Introductions
Engagements
Pharmacology
Temporary Placement
Lead Change
Milestone
Deployed
England
Interdisciplinary Research
Acting
Consideration
Breaking
Oversight
Negotiation
Logic Synthesis
Biomarkers
Clinical Trials
Poland
Chemical
Licensing
Organic Chemistry
Contractors
Antibacterial
Commercialization
Symposium
Efficacy
Medicine
Active
Therapists
Development
Laboratory
Agreement
Model Development
Market Opportunity Assessment
Skype
Virtual
Steering
Pharmaceutical Research
European Union
Start Ups
Founding
Nih
Pharmaceutics
Scottish
Patents
Financial Advisory
Leadership
Venture Capital
Parallel Synthesis
Molecular Diagnostics
Applications
Budgets
Forums
Pathway
Business Strategy
CRO
Computational
LinkedIn
Capital
Commercial Real Estate
Commercial Products
Microsoft Excel
North America
Tissue
Medicinal Chemistry
Conferences
Mergers and Acquisitions
Internet Protocols
CMO
Angels
Lead Optimisation
Research
Council
Internal Audit
Research and Development R&d
Business Systems
Renewal
DoD
Prognosis
Partnerships
Portfolio
Research and Development
Good Laboratory Practice
Roger Frechette Summary
Roger Frechette, based in Boston, MA, US, is currently a Entrepreneur in Residence, US-Israel HealthTech Hub Accelerator at Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA. Roger Frechette brings experience from previous roles at Jeevan Therapeutics, New England PharmAssociates (NEPA) and Akelos Inc. Roger Frechette holds a NIH Postoctoral Fellowship in Organic Chemistry @ Yale University. With a robust skill set that includes Conceptual Modeling, Scientific Background, Admet, Biology, Engagement and more. Roger Frechette has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Roger Frechette?
Find contact details for 700 million professionals.